PS Ratio: 17.81

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 17.81 is 97% below its estimated 3-year average of 591.67, near the low end of its estimated 3-year range (2.51–7168.30).

As of 2026-10-06T21:57:08.391Z. 253.83% above its estimated 12-month average of 5.03.

IOVA PS Ratio Metrics

P/S vs. estimated history

At 17.81, P/S is near its estimated 3-year median — higher than 51% of readings in its estimated 3-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The P/S ratio for IOVA stock is 17.81.

Is Iovance Biotherapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 17.81 is 97% below its estimated 3-year average of 591.67, near the low end of its estimated 3-year range (2.51–7168.30).

What is the estimated TTM average P/S ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The estimated TTM average P/S ratio for IOVA stock is 5.03.

What is the estimated 3Y average P/S ratio for Iovance Biotherapeutics, Inc. (IOVA)?

The estimated 3Y average P/S ratio for IOVA stock is 373.82.

Showing the most recent 260 of 792 data points. The chart above shows the full history.

Related Metrics